Diligent Investors LLC Takes $284,000 Position in Oracle Corporation $ORCL

Diligent Investors LLC purchased a new position in shares of Oracle Corporation (NYSE:ORCL) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 1,300 shares of the enterprise software provider’s stock, valued at approximately $284,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Nuveen LLC purchased a new stake in Oracle during the 1st quarter worth $732,692,000. Vanguard Group Inc. boosted its position in Oracle by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 160,925,413 shares of the enterprise software provider’s stock valued at $22,498,982,000 after buying an additional 3,513,464 shares during the last quarter. Kingstone Capital Partners Texas LLC acquired a new stake in shares of Oracle during the second quarter valued at about $731,512,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Oracle by 79.2% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,638,951 shares of the enterprise software provider’s stock worth $648,572,000 after acquiring an additional 2,049,687 shares during the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Oracle by 840.7% in the second quarter. Assenagon Asset Management S.A. now owns 2,119,473 shares of the enterprise software provider’s stock worth $463,380,000 after acquiring an additional 1,894,157 shares in the last quarter. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Insider Buying and Selling

In other news, insider Michael D. Sicilia sold 33,845 shares of the business’s stock in a transaction on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the transaction, the insider owned 132,656 shares of the company’s stock, valued at approximately $42,603,800.96. The trade was a 20.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Rona Alison Fairhead acquired 480 shares of the company’s stock in a transaction that occurred on Monday, July 7th. The stock was purchased at an average cost of $233.87 per share, for a total transaction of $112,257.60. Following the acquisition, the director owned 22,110 shares in the company, valued at approximately $5,170,865.70. This trade represents a 2.22% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 104,314 shares of company stock valued at $31,272,223 in the last three months. 42.20% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on ORCL shares. Westpark Capital raised their price objective on Oracle from $195.00 to $246.00 and gave the company a “buy” rating in a research note on Thursday, June 12th. CIBC reissued a “buy” rating on shares of Oracle in a research report on Monday, June 9th. Berenberg Bank lifted their price target on shares of Oracle from $202.00 to $306.00 and gave the stock a “hold” rating in a research note on Monday, September 15th. The Goldman Sachs Group upped their price target on shares of Oracle from $195.00 to $310.00 and gave the company a “neutral” rating in a report on Monday, September 15th. Finally, Evercore ISI raised their price objective on shares of Oracle from $270.00 to $340.00 and gave the stock an “outperform” rating in a report on Wednesday, September 10th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $304.71.

Oracle Price Performance

Shares of NYSE:ORCL opened at $286.23 on Friday. The company has a market cap of $815.99 billion, a PE ratio of 66.26, a P/E/G ratio of 3.08 and a beta of 1.53. Oracle Corporation has a fifty-two week low of $118.86 and a fifty-two week high of $345.72. The firm has a 50-day simple moving average of $262.53 and a 200 day simple moving average of $205.48. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33.

Oracle (NYSE:ORCL) last issued its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The business had revenue of $14.93 billion during the quarter, compared to the consensus estimate of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business’s revenue was up 12.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, sell-side analysts anticipate that Oracle Corporation will post 5 EPS for the current year.

Oracle Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Thursday, October 9th. Oracle’s dividend payout ratio (DPR) is presently 46.30%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.